Antibodies of FTO


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
FTOProduct_ID: RN121PW
Lot_ID: 1
Source: MBLI
Target Name: FTO-human		 HepG2_MBLI_RN121PW_001_FTO.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using FTO specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-FTO antibody (lanes under 'FTO').
 FTO-HEPG2.png<br>Caption: Western blot following shRNA against FTO in HepG2 whole cell lysate using FTO specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against FTO.FTO protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.
 K562_MBLI_RN121PW_001_FTO.png<br>Caption: IP-Western Blot analysis of K562 whole cell lysate using FTO specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 10% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-FTO antibody (lanes under 'FTO').
 FTO-K562.png<br>Caption: Western blot following shRNA against FTO in k562 whole cell lysate using FTO specific antibody. Lane 1 is a ladder, lane 2 is k562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against FTO.FTO protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.